ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
A fovea-centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease.
Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBlood biomarkers detect Alzheimer's disease (AD), but tissue correlates of early tau pathology and glial activation remain unclear. We investigated whether multimodal retinal measures capture a focal prodromal AD (pAD) pattern linked to plasma biomarkers.
methodsThirty-eight individuals with pAD and 40 controls underwent optical coherence tomography (OCT), OCT-angiography (OCT-A), and electroretinography (ERG). Plasma p-tau217, p-tau181, glial fibrillary acidic protein (GFAP) Aβ42 and Aβ40 were quantified, adjusting for age, sex, and vascular risk factors.
resultsBetween-group differences were restricted to parafoveal OCT-A measures. Within the pAD group, higher p-tau217/Aβ42 and GFAP showed consistent associations with foveal measures: increased ganglion cell-inner plexiform layer (GCIPL) thickness, capillary density, altered foveal avascular zone (FAZ), and reduced photopic negative-response amplitude. These associations were absent in controls. Mediation analyses indicated that foveal GCIPL thickness largely accounted for blood biomarker-microvascular/ERG associations. DISCUSSION: pAD exhibits a spatially consistent, fovea-centered neurovascular and functional signature-tracking plasma tau phosphorylation and glial activation, supporting the fovea as a sensitive region in early disease-related processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.